Lung Cancers Completed Phase 2 Trials for Vandetanib (DB05294)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00687297Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung CancerTreatment
NCT00410189BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLCTreatment
NCT00066313ZD6474 in Treating Patients With Small Cell Lung CancerTreatment